{
    "code": "01032122",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01032122",
    "time": "2019-11-22 03:28:17",
    "許可證字號": "衛署藥製字第032122號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/02\/01",
    "發證日期": "79\/02\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103212205",
    "中文品名": "&quot;信東&quot; 沙特靜脈點滴注射液５公絲\/公撮（梯尼達諾）",
    "英文品名": "SATA INJECTION FOR INTRAVENOUS INFUSION 5MG\/ML (TINIDAZOLE) &quot;S.T.&quot;",
    "適應症": "預防外科手術之厭氧菌感染",
    "劑型": "27D注射液劑",
    "包裝": "100、250、300、500、1000公撮瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0908703200  信東生技股份有限公司",
        "申請商地址": "桃園市桃園區介壽路２２號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812001500",
            "成分名稱": "TINIDAZOLE",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "14 SATA Injection for Intravenous Infusion 5mg／ml(Tinidazole)(衛署藥製字第032122號 G-1568)-103-06-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01032122&Seq=002&Type=9"
        },
        {
            "title": "54191470 SATA Inj. (L-100ml)-昱和-(印刷版次4)-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01032122&Seq=001&Type=8"
        }
    ]
}